MKMahboubeh Belali Kharaji

Mahboubeh Belali Kharaji

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mahboubeh Belali Kharaji has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pulmonary radiologic findings based on Warrick score as a predictor of COVID-19 patients’ outcomes

    by Farshad Gharebakhshi, Sara Abbasian, Mahsa Shariati Sough, Elahe Zaremoghadam, Faraz Zandiyeh, Golmis Abdolmohammadi, Aref Zarei, Zahra Tavassoli, Anahita Kalirad, Mahboubeh Belali Kharaji

    Introduction: Predicting factors related to the severity and mortality of coronavirus disease 2019 (COVID-19) patients can significantly help in better management of their treatment. Objectives: This study aimed to investigate the correlation between pulmonary radiologic findings based on the Warrick score and COVID-19 patients’ outcomes. Patients and Methods: This descriptive-analytical study was conducted on 436 COVID-19 patients hospitalized at Shahid Mohammadi hospital in Bandar Abbas. Pulmonary radiologic findings were scored based on the Warrick score. Outcomes of COVID-19 patients, including disease severity and mortality, were followed. Independent T-test and binary logistic regression were conducted to explore the correlation between the pulmonary radiologic findings and patients’ outcomes. Results: Results showed that the correlation between pulmonary radiologic findings with both disease severity and mortality was significant, since higher pulmonary involvement caused greater severity and mortality. The Warrick score difference between dead and recovered patients and low and high disease severity were significant, therefore greater Warrick score caused more disease severity and mortality. Conclusion: Pulmonary radiologic findings based on the Warrick score can use as a predictor of COVID-19 patients’ outcomes.


  • Open Access

    Biomarkers in IgA nephropathy; an update to recent data

    by Rokhsare Zareie, Mahsa Asadollahi Hamedani, Reyhaneh Sadeghian, Yaser Khanchemehr, Mahboubeh Belali Kharaji, Elahe Zaremoghadam, Negar Shahkarami, Atena Samareh Fekri

    Biomarkers are molecules that can be measured in the body and can reflect disease activity or progression. They can be used to diagnose and monitor disease, predict treatment response, and identify potential therapeutic targets. Several types of biomarkers have been studied in the context of IgA nephropathy, including protein, gene expression, epigenetic, and microRNA biomarkers. Biomarkers have the potential to improve the accuracy and specificity of the diagnosis of IgA nephropathy and predict the disease progression and response to treatment. However, further studies are needed to validate their diagnostic value in larger cohorts of patients and to integrate them into clinical practice. The development of multi-omics approaches that combine different types of biomarkers may provide a more comprehensive understanding of the disease pathogenesis and potential treatments.

  • Open Access

    Onconephropathology; an emerging field of medicine

    by Anna Ghorbani, Marzieh Soltanian, Farzaneh Barkhordari Ahmadi, Mahsa Asadollahi Hamedani, Mahboubeh Belali Kharaji, Najmeh Parsai, Amirhossein Khoshghadam

    Onconephropathology; an emerging field of medicine